Syros Pharmaceuticals, Inc. - common stock (SYRS): Price and Financial Metrics
Syros Pharmaceuticals, Inc. - common stock (SYRS)
Today's Latest Price: $9.17 USD
Updated Sep 25 4:00pm
Add SYRS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
SYRS Stock Summary
- With a price/sales ratio of 63.27, Syros Pharmaceuticals Inc has a higher such ratio than 96.39% of stocks in our set.
- With a year-over-year growth in debt of 150.21%, Syros Pharmaceuticals Inc's debt growth rate surpasses 90.38% of about US stocks.
- As for revenue growth, note that SYRS's revenue has grown 198.65% over the past 12 months; that beats the revenue growth of 96.84% of US companies in our set.
- Stocks that are quantitatively similar to SYRS, based on their financial statements, market capitalization, and price volatility, are CNCE, AGIO, DRNA, RGNX, and GLYC.
- SYRS's SEC filings can be seen here. And to visit Syros Pharmaceuticals Inc's official web site, go to www.syros.com.
SYRS Stock Price Chart Technical Analysis Charts
SYRS Price/Volume Stats
| Current price | $9.17 | 52-week high | $14.69 |
| Prev. close | $8.97 | 52-week low | $4.26 |
| Day low | $8.90 | Volume | 301,184 |
| Day high | $9.48 | Avg. volume | 330,831 |
| 50-day MA | $11.41 | Dividend yield | N/A |
| 200-day MA | $8.85 | Market Cap | 419.64M |
Syros Pharmaceuticals, Inc. - common stock (SYRS) Company Bio
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing medicines that control genes to transform the lives of patients with cancer, immune-mediated diseases, and other diseases. The company was founded in 2011 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...